Alvotech (ALVO)
14.51
+0.03
(+0.21%)
USD |
NASDAQ |
May 02, 16:00
14.51
0.00 (0.00%)
Pre-Market: 20:00
Alvotech Revenue (Quarterly): 53.39M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 53.39M |
September 30, 2023 | 17.79M |
June 30, 2023 | 4.391M |
March 31, 2023 | 15.86M |
December 31, 2022 | 23.86M |
Date | Value |
---|---|
September 30, 2022 | 19.05M |
June 30, 2022 | 39.67M |
March 31, 2022 | 0.452M |
December 31, 2021 | 34.76M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.452M
Minimum
Mar 2022
53.39M
Maximum
Dec 2023
23.25M
Average
19.05M
Median
Sep 2022
Revenue (Quarterly) Benchmarks
AbbVie Inc | 12.31B |
Moolec Science SA | 0.2521M |
Teva Pharmaceutical Industries Ltd | 4.457B |
Johnson & Johnson | 21.38B |
Procaps Group SA | 118.41M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -276.56M |
Total Expenses (Quarterly) | 130.54M |
EPS Diluted (Quarterly) | -1.22 |
Enterprise Value | 5.006B |
Gross Profit Margin (Quarterly) | -5.67% |
Profit Margin (Quarterly) | -518.0% |
Earnings Yield | -16.75% |
Normalized Earnings Yield | -12.68 |